Bharat Biotech's nasal vax priced at Rs 800 for private markets

Bharat Biotech International Limited on Tuesday said its COVID-19 intranasal vaccine iNCOVACC, which is now available on CoWIN portal, is priced at Rs 800 (excluding GST) for private markets and Rs......

'Big Boost': Bharat Biotech's nasal vaccine against Covid cleared for use

The Drugs Controller General of India (DCGI) on Tuesday approved Bharat Biotech's intranasal Covid vaccine for restricted emergency use in those aged above 18 years. "Big Boost to India's Fight......

Bharat Biotech completes phase-III trials for nasal Covid vaccine

Bharat Biotech International Ltd (BBIL) on Monday said it has completed the phase-III and booster dose trials for its intranasal Covid-19 vaccine BBV154, and it has proven to be safe. Photograph:......

Govt panel recommends regular market approval for Covishield, Covaxin

An expert panel of India's central drug authority on Wednesday recommended granting regular market approval to COVID vaccines Covishield and Covaxin for use in adult population subject to certain......

COVID-19 vaccine: The Need for Caution

History shows us that even effective vaccines could have unknown side effects that could develop over time, warns former Cabinet Secetary K M Chandrasekhar. On July 2, the Indian Council of......